Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Infective Ribonucleic Acid from the Viruses of Talfan and Teschen Diseases

Abstract

INFECTIVE ribonucleic acids have been obtained from several animal viruses by the cold phenol method described by Gierer and Schramm1. In general, however, most of the experiments have been done with crude suspensions, and it has not always been clear whether the infective ribonucleic acid was derived from the virus itself or from a viral precursor or other related material. The work of Huppert and Sanders2 with mouse encephalomyocarditis virus has shown clearly that the infective ribonucleic acid which can be obtained from mouse carcinoma cells infected with this virus has its origin in a viral precursor and not in the virus itself. In fact, infective ribonucleic acid cannot be extracted from this virus by the cold phenol method. On the other hand, it is likely that the infective material which can be obtained from suspensions of tissues infected with the viruses of poliomyelitis3, mouse encephalomyelitis4, Mengo encephalitis5, Murray Valley encephalitis6 and foot-and-mouth disease7,8 by this method is being derived from the viruses themselves. This difference in behaviour emphasizes the differences in the chemical structures of the viruses. Furthermore, the work of Wecker9 has shown that purified Western equine encephalomyelitis virus, which does not yield any infective ribonucleic acid on treatment with cold phenol, can be made to do so if the extraction is carried out at 40–50° C.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gierer, A., and Schramm, G., Nature, 177, 702 (1956).

    Article  ADS  CAS  Google Scholar 

  2. Huppert, J., and Sanders, F. K., Nature, 182, 515 (1958).

    Article  ADS  CAS  Google Scholar 

  3. Koch, G., Koenig, S., and Alexander, H. E., Virology, 10, 329 (1960).

    Article  CAS  Google Scholar 

  4. Franklin, R. M., Wecker, E., and Henry, C., Virology, 7, 220 (1959).

    Article  CAS  Google Scholar 

  5. Colter, J. S., Bird, H. H., Moyer, A. W., and Brown, R. A., Virology, 4, 522 (1957).

    Article  CAS  Google Scholar 

  6. Ada, G. L., and Anderson, G. S., Nature, 183, 799 (1959).

    Article  ADS  CAS  Google Scholar 

  7. Brown, F., and Stewart, D. L., Virology, 7, 408 (1959).

    Article  CAS  Google Scholar 

  8. Mussgay, M., and Strohmaier, K., Zbl. Bakt., I, Orig., 173, 163 (1958).

    CAS  Google Scholar 

  9. Wecker, E., Virology, 7, 241 (1959).

    Article  CAS  Google Scholar 

  10. Harding, J. D. J., Done, J. T., and Kershaw, G. F., Vet. Rec., 69, 824 (1957).

    Google Scholar 

  11. Chaproniere, D. M., Done, J. T., and Andrewes, C. H., Brit. J. Exp. Path., 39, 74 (1958).

    CAS  Google Scholar 

  12. Kohn, J., Nature, 183, 1055 (1959).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BROWN, F., STEWART, D. Infective Ribonucleic Acid from the Viruses of Talfan and Teschen Diseases. Nature 187, 714–715 (1960). https://doi.org/10.1038/187714a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/187714a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing